|
|
|
|
|
Contact: Media Relations Officer
AAMC Press Room
Oct. 28-31, 2000, Hyatt Regency Chicago
312-565-4270, Skyway 261Embargoed for Release
7:00 p.m., EST, Oct. 28, 2000AAMC Honors Leaders in Academic Medicine
Washington, D.C., October 28, 2000 -- The Association of American Medical Colleges (AAMC) recognized the distinguished careers of three individual leaders in medical education and science with national honors presented at the AAMC's 111th annual meeting in Chicago.
Abraham Flexner Award for Distinguished Service to Medical Education
Howard S. Barrows, M.D., director of the problem-based learning initiative at Southern Illinois University School of Medicine, is this year's recipient of the Abraham Flexner Award for Distinguished Service to Medical Education. The Association established the award in 1958 to recognize extraordinary individual contributions to medical schools and to the medical education community as a whole. For over 40 years, Dr. Barrows has been inventing educational tools and pioneering educational methods that have, in large part, defined the field of medical education today. Perhaps most significantly, he developed the Problem-Based Learning model (PBL). A small group, student-centered, case-based method of education, PBL is one form of an active, participatory model that has since been called for by major studies of medical education reform.
Dr. Barrow's work with PBL led him to create the idea of "standardized patients." By training actors or citizens to represent medical patients, Dr. Barrows opened the door to a broad range of opportunities for students to practice their clinical skills and for educators to assess their students. He was granted the first annual John P. Hubbard Award by the National Board of Medical Examiners in 1984 for this work.
Dr. Barrows received his M.D. degree from the University of Southern California School of Medicine, and completed his internship and first year of neurology residency at the Lenox Hill Hospital in New York City. He completed his residency at Columbia Presbyterian Medical Center, becoming chief resident in Neurology on Special Traineeship from the National Institutes of Health during his last year. A productive writer, he has participated in the writing of over 400 journal articles as well as 19 books.
David E. Rogers Award
Jeremiah Stamler, M.D., professor Emeritus, in the Department of Preventive Medicine at Northwestern University School of Medicine, is the 2000 recipient of the David E. Rogers Award. This award is jointly sponsored by the AAMC and the Robert Wood Johnson Foundation (RWJF) and honors David E. Rogers, M.D., a former president of the Foundation and an exemplar of academic medicine's commitment to meeting the health needs of our country. The award recognizes a medical school faculty member who has made major contributions to improving the health and health care of the American people.
Dr. Stamler's career has spanned more than five decades. Working to elucidate the causes, epidemiology, natural history, prevention, and control of hypertensive and atherosclerotic diseases, Dr. Stamler has headed efforts in the primary and secondary prevention of cardiovascular disease. He played a leading role in the landmark Chicago People's Gas Company study in 1957 that followed some 3,200 subjects for over 30 years. By tracking coronary risk factors, Dr. Stamler's group developed and fostered the concept that those subjects at the highest levels of risk had the highest mortality from cardiac heart disease and stroke. This concept was a critically important contribution to the public policy that emerged over the ensuing years for prevention and control of cardiac heart disease. In the late 1950s, he developed the Chicago Coronary Prevention Evaluation Program, the first multi-factor primary prevention trial in the world.
Dr. Stamler received his M.D. in 1943 from Long Island College of Medicine, Downstate Medical Center, Brooklyn. Upon completion of his fellowship at the Long Island College of Medicine, he joined the Medical Research Institute of the Michael Reese Hospital, where he became an Established Investigator of the American Heart Association. In the late 1950s he was named heart disease control officer at the Chicago Health Department and began volunteering at Northwestern University.
In 1972, Dr. Stamler joined Northwestern full-time as chairman of the newly established Department of Community Health and Preventive Medicine. Since resigning that post in 1986, Dr. Stamler has remained active in a number of major studies, committees, and professional organizations. He and his wife were granted a joint Lifetime Achievement Award from the American Heart Association of Metropolitan Chicago in 1995.
Baxter Award for Distinguished Research in the Biomedical Sciences
Ferid Murad, M.D., chair of the Department of Integrative Biology at the University of Texas Houston Medical School, is the recipient of the 2000 Baxter Award for Distinguished Research in the Biomedical Sciences. This award recognizes outstanding clinical or laboratory research conducted by a medical school faculty member. The Baxter Award was established in 1981 and is funded by the Baxter Foundation. Dr. Murad's discovery in the 1970s-that compounds such as azide, nitrite, hydroxylamine, and nitroglycerin lead to nitric oxide formation-opened the door for research on nitric oxide's effect on cyclic GMP signaling pathways. In 1998, he was awarded the Nobel Prize in Medicine and Physiology, which he shared with two other scientists, Drs. Louis Ignarro and Robert Furchgott, for their pioneering research in the field of nitric oxide.
Today, Dr. Murad continues to blaze new scientific trails, most recently examining a novel mechanism by which the signaling pathway regulates protein function. These discoveries have led to a better understanding of how information is transmitted between cells. Dr. Murad received the Albert and Mary Lasker Basic Medical Research Award in 1996 and was subsequently elected to the National Academy of Sciences.
After receiving his M.D. and Ph.D. in 1965 from Case Western Reserve University School of Medicine and finishing his residency at Massachusetts General Hospital, Dr. Murad took a position with the U.S. Public Health Service. He then joined the faculty at the University of Virginia School of Medicine, serving as director of both the Clinical Research Center and the Division of Clinical Pharmacology until 1981. Dr. Murad then accepted a position with Stanford University and became chief of medicine at the Palo Alto VA Medical Center. In 1988, he joined Abbott Laboratories, leaving in 1997 for the University of Texas Houston Medical School, where he is the first director of Clinical Pharmacology and chairman of the Department of Integrative Biology, Pharmacology and Physiology.
###
The Association of American Medical Colleges represents the 125 accredited U.S. medical schools; the 16 accredited Canadian medical schools; some 400 major teaching hospitals, including 74 Veterans Administration medical centers; 91 academic and professional societies representing nearly 88,000 faculty members; and the nation's 67,000 medical students and 102,000 residents.
Additional information about the AAMC and U.S. medical schools and teaching hospitals available at www.aamc.org/newsroom
|
Contact Us © 1995-2008 AAMC Terms and Conditions Privacy Statement |